Market Research Report
Vital Signs Monitoring Devices Market by Product (Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices), by End User - Global Opportunity Analysis and Industry Forecast, 2014-2022
|Published by||Allied Market Research||Product code||421134|
|Published||Content info||234 Pages
Delivery time: 1-2 business days
|Vital Signs Monitoring Devices Market by Product (Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices), by End User - Global Opportunity Analysis and Industry Forecast, 2014-2022|
|Published: December 1, 2016||Content info: 234 Pages||
Vital signs monitoring devices are used for the measurement of vital parameters, including blood pressure, heart rate, respiratory rate, and body temperature, to monitor physical functioning of the body. They offer clinically relevant information regarding the health status of the patients. This information plays a vital role in identifying the presence of any acute medical problem or chronic disease state. Vital signs of a patient are recorded at the emergency department, pre- and post-surgery, and during treatment at hospitals.
The global vital signs monitoring devices market is expected to reach $5,491 million by 2022 from $3,694 million in 2015, growing at a CAGR of 5.8% during the study period. This market is expected to witness significant growth during the forecast period due to increase in importance of vital signs monitoring devices in home care settings and improved reimbursement scenario for pulse oximeters in developed countries. In addition, upsurge in geriatric population and rise in incidence rate of cardiovascular disorders such as hypertension and other preexisting health conditions including COPD, sleep apnea, and infectious diseases have fueled the demand for vital signs monitoring devices. Moreover, increase in use of vital signs monitoring devices for fitness monitoring and rise in ambulatory surgery centers that use vital signs monitoring devices routinely have fueled the market growth. However, lack of awareness about these devices in the low- and middle-income countries hamper the market growth.
The vital signs monitoring devices market is segmented on the basis of product type, end user, and geography. Based on product type, the market is segmented into blood pressure monitoring devices, pulse oximeters, and temperature monitoring. On the basis of end user, the market is classified into hospitals & clinics, ambulatory surgery centers, and home care settings. The market is analyzed on the basis of four geographical regions, which include North America, Europe, Asia-Pacific, and LAMEA.
Prominent players have adopted product development including product launches, approvals, and clinical trials as their key developmental strategy to expand their product portfolio. For instance, in July 2016, SunTech (now Halma plc) received FDA clearance for its next generation spot-check vital signs device, SunTech C40. The device helps in the accurate measurement of blood pressure plus other vital signs including temperature and pulse oximetry using advanced features and digital connectivity. Moreover, reimbursement policies for pulse oximeters have fueled the demand for vital signs monitoring products. For instance, Medicare offers reimbursement for pulse oximeters used for a pulmonary disease(s) in case of using diagnosis code ICD-9-CM, which describes a patient's condition and the motive of using the service or procedure. The present procedural technology identifies three codes for oximetry-94760, 94761, and 94762.